Skip to main content
Ir a la página de inicio de la Comisión Europea (se abrirá en una nueva ventana)
español es
CORDIS - Resultados de investigaciones de la UE
CORDIS
Contenido archivado el 2024-05-30

Deciphering the molecular basis of regulatory T cell suppression

Objetivo

Regulatory T cells (TREG) comprise a subset of CD4+ T cells that maintain immunological tolerance by suppressing immune activation in a dominant manner. TREG helps shaping the immune responses to autoantigens, alloantigens, tumors, pathogens and allergens, and are thus considered a therapeutical target in a large variety of diseases. One aspect of TREG biology that remains poorly understood is what molecular program(s) are induced in cells that are being actively suppressed by TREG. The specific aims described below are designed to provide a better understanding of the molecular changes that occur as a result of TREG-mediated suppression and determine if the biochemical pathways altered by TREG-mediated suppression can be exploited for therapeutical purposes.

1. Characterize the molecular changes that occur in CD4+ T cells and dendritic cells that are being suppressed by TREG using gene profiling and cell signaling experimental approaches.

2. Evaluate the importance and therapeutical potential of genes with an expression
profile altered by TREG-mediated suppression in animal models of human diseases.

Ámbito científico (EuroSciVoc)

Palabras clave

Programa(s)

Tema(s)

Convocatoria de propuestas

FP7-PEOPLE-IRG-2008
Consulte otros proyectos de esta convocatoria

Régimen de financiación

MC-IRG - International Re-integration Grants (IRG)

Coordinador

KAROLINSKA INSTITUTET
Aportación de la UE
€ 100 000,00
Dirección
NOBELS VAG 5
171 77 STOCKHOLM
Suecia
Región
Östra Sverige Stockholm Stockholms län
Tipo de actividad
Higher or Secondary Education Establishments
Enlaces
Coste total
Sin datos